Mr. Don Bailey serves as Independent Chairman of the Board of STAAR Surgical Company. He has served as a Director and Chairman since April 2005, and serves as the chairman of the Nominating and Governance Committee of the Board of Directors. Since November 26, 2007, Mr. Bailey has served as President, Chief Executive Officer and a director of Questcor Pharmaceuticals, Inc., having served as its interim President from May 2007 and as a director since May 2006. In addition, he served as Chairman of the Board of Comarco, Inc., a provider of wireless test products for the wireless industry and a maker of emergency call box systems and mobile power products for handheld devices, from 1998 until August 31, 2007. He also served from June 1990 to April 2000 as President of Comarco, Inc. and as its Chief Executive Officer from January 1991 to April 2000
Independent Chairman of the Board
Age: 66 Chairman Since 2005 MBA
|Bailey earned his BS degree in Mechanical Engineering from Drexel University in 1968, his MS degree in Operations Research from the University of Southern California in 1971 and his MBA degree from Pepperdine University in 1986.|
The company has return on total asset (ROA) of 1.71 % which means that it generated profit of $1.71 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (5.76) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 7.17 M in liabilities with Debt to Equity (D/E) ratio of 0.23 which may suggest the company is not taking enough advantage from borrowing. STAAR Surgical Company has Current Ratio of 2.41 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Entity SummarySTAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures and sells implantable lenses for the eye. STAAR Surgical Company [STAA] is traded on NASDAQ General Markets in USA. It is located in Monrovia, CA and employs 301 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| STAA Nasdaq
STAAR Surgical Company
STAAR Surgical Company has less than 1.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.
STAAR price boundaries
Promote STAAR and Don Bailey